483 Biomarin Pharmaceutical Feb 2014

483 Biomarin Pharmaceutical Feb 2014

Lance De Souza FDA, Stephanie Slater FDA$119.00 - Available Now

FDA investigators audited the Biomarin Pharmaceutical - San Rafael, CA, United States facility and issued inspectional observations (via FDA 483) on 17 Feb 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Feb 2014
  • Location: San Rafael, United States
  • FEI: 3010446870
Add To Cart